Search Page

1

Cite

Share

Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir.

Li C, Quenelle DC, Prichard MN, Drach JC, Zemlicka J. Li C, et al. Among authors: quenelle dc. Bioorg Med Chem. 2012 Apr 15;20(8):2669-74. doi: 10.1016/j.bmc.2012.02.031. Epub 2012 Feb 20. Bioorg Med Chem. 2012. PMID: 22417649 Free PMC article.

Cite

Share

2

Cite

Share

Anti-HSV activity of serpin antithrombin III.

Quenelle DC, Hartman TL, Buckheit RW, Prichard MN, Lynn RG. Quenelle DC, et al. Int Trends Immun. 2014 Apr;2(2):87-92. Int Trends Immun. 2014. PMID: 25215309 Free PMC article.

Cite

Share

3

Cite

Share

Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.

Quenelle DC, Birkmann A, Goldner T, Pfaff T, Zimmermann H, Bonsmann S, Collins DJ, Rice TL, Prichard MN. Quenelle DC, et al. Antiviral Res. 2018 Jan;149:1-6. doi: 10.1016/j.antiviral.2017.11.002. Epub 2017 Nov 4. Antiviral Res. 2018. PMID: 29113740 Free PMC article.

Cite

Share

4

Cite

Share

Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.

Prichard MN, Quenelle DC, Hartline CB, Harden EA, Jefferson G, Frederick SL, Daily SL, Whitley RJ, Tiwari KN, Maddry JA, Secrist JA 3rd, Kern ER. Prichard MN, et al. Among authors: quenelle dc. Antimicrob Agents Chemother. 2009 Dec;53(12):5251-8. doi: 10.1128/AAC.00417-09. Epub 2009 Sep 21. Antimicrob Agents Chemother. 2009. PMID: 19770274 Free PMC article.

Cite

Share

5

Cite

Share

Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.

Markert JM, Cody JJ, Parker JN, Coleman JM, Price KH, Kern ER, Quenelle DC, Lakeman AD, Schoeb TR, Palmer CA, Cartner SC, Gillespie GY, Whitley RJ. Markert JM, et al. Among authors: quenelle dc. J Virol. 2012 May;86(9):5304-13. doi: 10.1128/JVI.06998-11. Epub 2012 Feb 29. J Virol. 2012. PMID: 22379082 Free PMC article.

Cite

Share

6

Cite

Share

Isolation and characterization of cidofovir resistant vaccinia viruses.

Becker MN, Obraztsova M, Kern ER, Quenelle DC, Keith KA, Prichard MN, Luo M, Moyer RW. Becker MN, et al. Among authors: quenelle dc. Virol J. 2008 May 14;5:58. doi: 10.1186/1743-422X-5-58. Virol J. 2008. PMID: 18479513 Free PMC article.

Cite

Share

7

Cite

Share

CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections.

Prichard MN, Kern ER, Hartline CB, Lanier ER, Quenelle DC. Prichard MN, et al. Among authors: quenelle dc. Antimicrob Agents Chemother. 2011 Oct;55(10):4728-34. doi: 10.1128/AAC.00545-11. Epub 2011 Jul 25. Antimicrob Agents Chemother. 2011. PMID: 21788472 Free PMC article.

Cite

Share

8

Cite

Share

Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections.

Kern ER, Prichard MN, Quenelle DC, Keith KA, Tiwari KN, Maddry JA, Secrist JA 3rd. Kern ER, et al. Among authors: quenelle dc. Antimicrob Agents Chemother. 2009 Feb;53(2):572-9. doi: 10.1128/AAC.01257-08. Epub 2008 Nov 24. Antimicrob Agents Chemother. 2009. PMID: 19029322 Free PMC article.

Cite

Share

9

Cite

Share

Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.

Quenelle DC, Prichard MN, Keith KA, Hruby DE, Jordan R, Painter GR, Robertson A, Kern ER. Quenelle DC, et al. Antimicrob Agents Chemother. 2007 Nov;51(11):4118-24. doi: 10.1128/AAC.00762-07. Epub 2007 Aug 27. Antimicrob Agents Chemother. 2007. PMID: 17724153 Free PMC article.

Cite

Share

10

Cite

Share

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

Quenelle DC, Kern ER. Quenelle DC, et al. Viruses. 2010 Dec;2(12):2681-95. doi: 10.3390/v2122681. Epub 2010 Dec 13. Viruses. 2010. PMID: 21994637 Free PMC article.

Cite

Share